In the NSCLC cohort, the phenotypes CD3+CD8+CD45RO+, CK+B7-H3+, CK+B7-H4+, CD3+B7-H4+, CD68+B7-H3+, CD68+B7-H4+, CK+OX40+, CD3+LAG3+, CD68+Arg-1+, CD66b+CD11b+, CD11b+Arg1+CD14+CD33+and CD11b+CD66b+CD33+ were observed in small quantities, and in some samples they were not found; this scarcity hindered the analysis and interpretation of those cell phenotypes, which is why those phenotypes were not included in the reproducibility analysis. This evidence concerns the gene CD276 and non-small cell lung carcinoma.